 |
 |
Harvey, There is currently an ongoing Phase II/III clinical trial of CEP 1347, which is being tested as a possible neuroprotective agent, that might help slow the progression of PD. The Parkinson Study Group , which is the coordinating center for the 65 sites where the CEP 1347 clinical trials are taking place, provides information on it web site. http://parkinson-study-group.org/Clinical%20Trials%20in%20Progress.html Look under the PRECEPT study. It appears enrollment for this study has just recently been completed this month. I have actually been following this trial for the Parkinson's Pipeline Project. Let me know if you would like any additional further information. Linda Herman On Sat, 6 Mar 2004 21:23:27 EST MyFirstname Mylastname Harvey Raider <[log in to unmask]> writes: > Does anybody have information on the CEP 1347study? > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: > mailto:[log in to unmask] > In the body of the message put: signoff parkinsn > ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn